BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gameiro A, Pereira N, Cardoso JC, Gonçalo M. Pyoderma gangrenosum: challenges and solutions. Clin Cosmet Investig Dermatol 2015;8:285-93. [PMID: 26060412 DOI: 10.2147/CCID.S61202] [Cited by in Crossref: 49] [Cited by in F6Publishing: 15] [Article Influence: 8.2] [Reference Citation Analysis]
Number Citing Articles
1 Freitas VMP, Pereira SM, Enokihara MMSES, Cestari SDCP. Pyoderma gangrenosum associated with left iliac vein compression syndrome: presentation of difficult diagnosis. An Bras Dermatol 2017;92:129-31. [PMID: 29267470 DOI: 10.1590/abd1806-4841.20176109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Jiang YY, Li J, Li Y, Wang Q, Liu S, Fang K, Qian JM, Jin HZ. Comparison of Clinical Features between Pyoderma Gangrenosum Concomitant by Inflammatory Bowel Disease and Idiopathic Pyoderma Gangrenosum. Chin Med J (Engl) 2017;130:2674-9. [PMID: 29133754 DOI: 10.4103/0366-6999.218004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
3 Ben Abdallah H, Fogh K, Bech R. Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: A semi-systematic review. Int Wound J 2019;16:511-21. [PMID: 30604927 DOI: 10.1111/iwj.13067] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
4 Alonso-León T, Hernández-Ramírez HH, Fonte-Avalos V, Toussaint-Caire S, E Vega-Memije M, Lozano-Platonoff A. The great imitator with no diagnostic test: pyoderma gangrenosum. Int Wound J 2020;17:1774-82. [PMID: 32779354 DOI: 10.1111/iwj.13466] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 DaCunha M, Siscos S, Downing M, Tarantino I, Hall J. Pyoderma gangrenosum controlled with rituximab. JAAD Case Rep 2019;5:593-5. [PMID: 31312710 DOI: 10.1016/j.jdcr.2019.04.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Slocum AMY. A surgeon's nightmare: pyoderma gangrenosum with pathergy effect mimicking necrotising fasciitis. BMJ Case Rep 2017;2017:bcr-2017-222145. [PMID: 29269363 DOI: 10.1136/bcr-2017-222145] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Abraham ZS, Thomas EP, Kahinga AA. Unilateral Pyoderma gangrenosum of the external ear in a resource-limited setting: Case report and literature review. Clin Case Rep 2021;9:2016-8. [PMID: 33936632 DOI: 10.1002/ccr3.3930] [Reference Citation Analysis]
8 Guaitoli G, Piacentini F, Omarini C, Andreotti A, Palma E, Papi S, De Pietri C, Conti A, Cascinu S, Tazzioli G. Post-surgical pyoderma gangrenosum of the breast: needs for early diagnosis and right therapy. Breast Cancer 2019;26:520-3. [PMID: 30564995 DOI: 10.1007/s12282-018-00940-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
9 Rodriguez I, Conti T, Bionda N. Microenvironment Influence of a Novel Bioengineered Wound Product, APIS®: A Preliminary In Vitro Analysis of Inflammatory Marker and Growth Factor Secretion. Int J Biomater 2021;2021:6612870. [PMID: 33824662 DOI: 10.1155/2021/6612870] [Reference Citation Analysis]
10 Li XL, Ma ZG, Huang WH, Chai EQ, Hao YF. Successful treatment of pyoderma gangrenosum with concomitant immunoglobulin A nephropathy: A case report and review of literature. World J Clin Cases 2018; 6(13): 703-706 [PMID: 30430129 DOI: 10.12998/wjcc.v6.i13.703] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Oppermann K, Cocco AR, Heck R, Bonamigo RR. PLECT or PPLECT? Granulomatous pyoderma gangrenosum in the differential diagnosis of the verrucous syndrome. An Bras Dermatol 2018;93:605-7. [PMID: 30066779 DOI: 10.1590/abd1806-4841.20187329] [Reference Citation Analysis]
12 Tanini S, Calugi G, Russo GL. Combination of negative pressure wound therapy and systemic steroid therapy in postsurgical pyoderma gangrenosum after reduction mammoplasty; a case of proven efficacy and safety. Dermatol Reports 2017;9:7209. [PMID: 29279772 DOI: 10.4081/dr.2017.7209] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Yamasaki K, Yamanaka K, Zhao Y, Iwano S, Takei K, Suzuki K, Yamamoto T. Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Twenty-six-week phase 3 open-label study. J Dermatol 2020;47:1383-90. [PMID: 32804433 DOI: 10.1111/1346-8138.15533] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Nanoudis S, Tsona A, Tsachouridou O, Morfesis P, Loli G, Georgiou A, Zebekakis P, Metallidis S. Pyoderma gangrenosum in a patient with chronic granulomatous disease: A case report. Medicine (Baltimore) 2017;96:e7718. [PMID: 28767612 DOI: 10.1097/MD.0000000000007718] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
15 Shi X, Cui ZG, Hou F, Xu H, Wang H, Su Z, Zhao HG. [Acute lymphoblastic leukemia complicated with pyoderma gangrenosum: a case report and literatures review]. Zhonghua Xue Ye Xue Za Zhi 2017;38:333-6. [PMID: 28468097 DOI: 10.3760/cma.j.issn.0253-2727.2017.04.014] [Reference Citation Analysis]